The CEO who loves AI autodidacts — and desperately needs his experts

Source Domain: fortune.com

Bob Bradway defines a successful leader in the AI era as an “autodidact,” someone self-taught and comfortable with uncertainty.
Bradway himself embodies this characteristic by spending his weekends learning new tools and programming languages.
He leads Amgen’s transformation by integrating AI into their practices, requiring his senior team to take AI courses.
Despite Amgen’s base in specialized scientific expertise, Bradway believes in harmonizing autodidact adaptability with expert knowledge.
He has long-term foresight, acquiring genomic data in 2012, which paved the way for AI integration in drug discovery.
Bradway emphasizes AI’s role in accelerating Amgen’s clinical development timelines and is focused on its potential beyond data handling.
He acknowledges the challenges of public apprehension and misinformation about AI but remains an optimistic advocate for its integration.
Bradway criticizes the hesitation of other CEOs towards investing in AI, advocating for early adoption due to the prolonged R&D timelines in biotech.

You may have missed